The recognition of unique cancer mutations could be responsible for complete cancer regressions in metastatic melanoma patients treated with immunotherapy, a new approach has found. This new approach may help develop more effective cancer immunotherapies, according to a study published in iClinical Cancer Research/i, a journal of the American Association for Cancer Research. "This study provides the technical solution to identify mutated tumor targets that can ...
Read MoreYou have just read an article categorized health
titled Cancer Mutations Identified As Targets Of Melanoma Immunotherapy.
Written by:
editor - Tuesday, July 1, 2014
There are currently no comments for "Cancer Mutations Identified As Targets Of Melanoma Immunotherapy"
Post a Comment